載入...
Preclinical Childhood Sarcoma Models: Drug Efficacy Biomarker Identification and Validation
Over the past 35 years, cure rates for pediatric cancers have increased dramatically. However, it is clear that further dose intensification using cytotoxic agents or radiation therapy is not possible without enhancing morbidity and long-term effects. Consequently, novel, less genotoxic, agents are...
Na minha lista:
| 發表在: | Front Oncol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4549564/ https://ncbi.nlm.nih.gov/pubmed/26380223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2015.00193 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|